Position in DNLI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$180
+$84 QoQ
Shares Held
7
+40.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#279
of 290 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rialto Wealth Management, LLC holds $899,727 across 71 Biotechnology names. DNLI ranks #66 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MESO |
Mesoblast Ltd
|
46,500 | $629,145 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199 | $98,849 | |
| 3 | ABSI |
Absci Corp
|
2,044 | $23,689 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
52 | $19,326 | |
| 5 | PBLS |
Parabilis Medicines, Inc.
|
508 | $13,903 | |
| 6 | PBYI |
Puma Biotechnology, Inc.
|
1,450 | $11,759 | |
| 7 | SLN |
Silence Therapeutics plc
|
1,021 | $11,210 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
27 | $8,127 |
All Filings in DNLI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180 | 7 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $96 | 5 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $132 | 8 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $29 | 2 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $27 | 2 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||